SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001563228-19-000002
Filing Date
2019-03-04
Accepted
2019-03-04 16:10:26
Documents
39
Period of Report
2017-09-30

Document Format Files

Seq Description Document Type Size
1 CONVERTED BY EDGARWIZ eastgatebiotechq3.2017.htm 10-Q 360907
2 EXHIBIT 31.1 exhibit31.1.htm EX-31 6422
3 EXHIBIT 31.2 exhibit31.2.htm EX-31 6529
4 EXHIBIT 32.1 exhibit32.1.htm EX-32 3330
5 EXHIBIT 32.2 exhibit32.2.htm EX-32 3537
  Complete submission text file 0001563228-19-000002.txt   1303306

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT etbi-20170930_cal.xml EX-101.CAL 27572
7 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT etbi-20170930_def.xml EX-101.DEF 9305
8 XBRL INSTANCE DOCUMENT etbi-20170930.xml EX-101.INS 92933
9 XBRL TAXONOMY EXTENSION LABELS LINKBASE DOCUMENT etbi-20170930_lab.xml EX-101.LAB 94349
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT etbi-20170930_pre.xml EX-101.PRE 94172
11 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT etbi-20170930.xsd EX-101.SCH 12592
Mailing Address 2681 EAST PARLEYS WAY - SUITE 204 SALT LAKE CITY UT 84109
Business Address 2681 EAST PARLEYS WAY - SUITE 204 SALT LAKE CITY UT 84109 8013223401
EASTGATE BIOTECH CORP (Filer) CIK: 0001099574 (see all company filings)

IRS No.: 870639378 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-52886 | Film No.: 19653818
SIC: 6799 Investors, NEC